Company intelligence / Profile preview

SBH Diagnostics

Natick, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

SBH Diagnostics is a CLIA-certified contract research organization (CRO) specializing in accurate and reproducible biomarker analysis services. It provides custom and multiplex-based cytokine and biomarker assays for drug development, clinical studies, and companion diagnostics, supporting a range of therapeutic areas. The company is known for assay development, qualification, and validation, and collaborates closely with SBH Sciences for broader research capabilities. It operates as a platform company offering a Biomarker Analysis Platform with more than 10 analytical pathways.

Therapeutic areas: CardiovascularImmunologyNeurologyMetabolic DisordersOncology
Modalities: Biomarker analysisCytokine analysis
Industry: Contract Research Organization

Partnerships

SBH Sciences

Beyond the preview

Go deeper on SBH Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SBH Diagnostics.

Explore the full profile